Risk Warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68.93% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Dear clients,

please note that due to acquisition of Celgene Corporation (CELG) by Bristol-Myers Squibb Company (BMY) announced earlier on November 20th, Earn stops offering CFD on CELG.

Any remaining positions in CELG shall be closed by the Company based on the the last available price on November 26, 2019, between 18:00 and 21:00 server time, after which the symbol will be closed (all related trading reports will still be available).

Please refer to Bristol-Myers Squibb official release for more details: https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-completes-acquisition-celgene-creating-le

A new symbol "BMY" for Bristol-Myers Squibb Company will be available for trading starting December 2, 2019.

Sincerely,
The Earn Team

Other news